Related Experiment Videos
Stem cell differentiation requires a paracrine pathway in the heart.
Atta Behfar1, Leonid V Zingman, Denice M Hodgson
1CNRS UPR1086, Centre de Recherches de Biochimie Macromoléculaire, Montpellier, France.
Summary
Transforming growth factor beta1 (TGF-beta) and BMP2 promote embryonic stem cell differentiation into cardiomyocytes. This signaling pathway is crucial for stem cell therapy in heart disease, enhancing cardiac function.
Area of Science:
- Cardiovascular Biology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Embryonic stem cells (ESCs) hold potential for cardiac repair.
- Understanding ESC differentiation into cardiomyocytes is critical for therapeutic applications.
- The role of specific signaling pathways in directing ESC cardiac fate requires elucidation.
Purpose of the Study:
- To investigate the role of transforming growth factor beta1 (TGF-beta) superfamily members, specifically TGF-beta and BMP2, in directing embryonic stem cell differentiation towards a cardiomyocyte lineage.
- To determine the necessity of TGF-beta/BMP2 signaling for in vitro and in vivo cardiac differentiation of ESCs.
- To assess the therapeutic potential of TGF-beta/BMP2-mediated ESC differentiation in a cardiac injury model.
Main Methods:
- Murine ESCs were treated with TGF-beta and BMP2, and expression of mesodermal and cardiac transcription factors was analyzed.
- Embryoid bodies were generated and assessed for cardiac differentiation markers and beating activity.
- Engineered ESCs were co-cultured with postmitotic cardiomyocytes or transplanted into infarcted myocardium.
- TGF-beta/BMP signaling pathways were inhibited using latency-associated peptide and/or noggin.
- Cardiac differentiation and functional integration of transplanted cells were evaluated in vivo.
Main Results:
- TGF-beta and BMP2 treatment upregulated cardiac-specific transcription factors (Nkx2.5, MEF2C) and mesodermal markers (Brachyury) in ESCs.
- Priming ESCs with TGF-beta/BMP2 enhanced cardiac differentiation, evidenced by increased beating areas and myofibrillogenesis.
- In vitro, ESCs differentiated into functional ventricular myocytes synchronized with host cardiomyocytes, a process boosted by TGF-beta/BMP2.
- Inhibition of TGF-beta/BMP signaling blocked ESC cardiac differentiation.
- In vivo, transplanted ESCs differentiated into cardiomyocytes within infarcted myocardium, improving contractile performance, contingent on intact TGF-beta/BMP2 signaling.
Conclusions:
- TGF-beta/BMP2 signaling is a key pathway that directs embryonic stem cell differentiation into cardiomyocytes.
- This signaling is essential for both in vitro and in vivo cardiac differentiation of ESCs.
- TGF-beta/BMP2-mediated ESC differentiation represents a promising therapeutic strategy for cardiac repair in diseased hearts.